Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Financial and Strategic SWOT Analysis Review

Date: September 6, 2017
Pages: 60
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S0BC3618789EN
Leaflet:

Download PDF Leaflet

Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Financial and Strategic SWOT Analysis Review
Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company, which offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s products find application in the treatment of various conditions related to psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. The company carries out product development, process chemistry, and manufacture of complex active pharmaceutical ingredients (APIs), over-the-counter products and formulations. It offers drugs in various dosage forms such as tablets, capsules, injectables, inhalers, ointments, creams and liquids. The company has manufacturing facilities in North America, Latin America, EMEA and Asia Pacific. Sun Pharma is headquartered in Mumbai, Maharashtra, India.

Sun Pharmaceutical Industries Ltd Key Recent Developments

Aug 11,2017: Sun Pharma reports Q1FY18 results
Jul 12,2017: Sun Pharmaceutical Industries Announces Appointment of Mr. Kalyansundaram Subramanian as the Director
Jul 07,2017: SUN Pharma: Intimation of settlement in re Modajmnil Antitrust Litigation matter
May 26,2017: Sun Pharma reports Q4 & FY17 results
Mar 14,2017: Sun Pharma Provides Update on Mohali Facility

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Sun Pharmaceutical Industries Ltd - Key Facts
Sun Pharmaceutical Industries Ltd - Key Employees
Sun Pharmaceutical Industries Ltd - Key Employee Biographies
Sun Pharmaceutical Industries Ltd - Major Products and Services
Sun Pharmaceutical Industries Ltd - History
Sun Pharmaceutical Industries Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Sun Pharmaceutical Industries Ltd - Business Description
Sun Pharmaceutical Industries Ltd - SWOT Analysis
SWOT Analysis - Overview
Sun Pharmaceutical Industries Ltd - Strengths
Sun Pharmaceutical Industries Ltd - Weaknesses
Sun Pharmaceutical Industries Ltd - Opportunities
Sun Pharmaceutical Industries Ltd - Threats
Sun Pharmaceutical Industries Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Sun Pharmaceutical Industries Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 11, 2017: Sun Pharma reports Q1FY18 results
Jul 12, 2017: Sun Pharmaceutical Industries Announces Appointment of Mr. Kalyansundaram Subramanian as the Director
Jul 07, 2017: SUN Pharma: Intimation of settlement in re Modajmnil Antitrust Litigation matter
May 26, 2017: Sun Pharma reports Q4 & FY17 results
Mar 14, 2017: Sun Pharma Provides Update on Mohali Facility
Mar 14, 2017: Sun Pharmaceutical Industries Provides Update on Mohali Facility
Mar 14, 2017: Sun Pharmaceuticals Announces Update on Mohali Facility
Feb 14, 2017: Sun Pharma reports Q3FY17 results
Dec 20, 2016: Sun Pharmaceutical Industries Voluntary withdrawal of 28 ANDAs
Dec 08, 2016: Sun Pharma Provide Update on USFDA Inspection for Halol facility

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sun Pharmaceutical Industries Ltd, Key Facts
Sun Pharmaceutical Industries Ltd, Key Employees
Sun Pharmaceutical Industries Ltd, Key Employee Biographies
Sun Pharmaceutical Industries Ltd, Major Products and Services
Sun Pharmaceutical Industries Ltd, History
Sun Pharmaceutical Industries Ltd, Subsidiaries
Sun Pharmaceutical Industries Ltd, Joint Venture
Sun Pharmaceutical Industries Ltd, Key Competitors
Sun Pharmaceutical Industries Ltd, Ratios based on current share price
Sun Pharmaceutical Industries Ltd, Annual Ratios
Sun Pharmaceutical Industries Ltd, Annual Ratios (Cont.1)
Sun Pharmaceutical Industries Ltd, Annual Ratios (Cont.2)
Sun Pharmaceutical Industries Ltd, Interim Ratios
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Sun Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Sun Pharmaceutical Industries Ltd, Performance Chart (2012 - 2016)
Sun Pharmaceutical Industries Ltd, Ratio Charts
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Sun Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Wockhardt Ltd
Unichem Laboratories Ltd
Torrent Pharmaceuticals Ltd
Lupin Ltd
IPCA Laboratories Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Dr. Reddy's Laboratories Ltd
Cadila Pharmaceuticals Ltd
Skip to top


Ask Your Question

Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: